[go: up one dir, main page]

ATE532853T1 - Verfahren zur herstellung einer plasmid-dna in pharmazeutischer qualität - Google Patents

Verfahren zur herstellung einer plasmid-dna in pharmazeutischer qualität

Info

Publication number
ATE532853T1
ATE532853T1 AT04787081T AT04787081T ATE532853T1 AT E532853 T1 ATE532853 T1 AT E532853T1 AT 04787081 T AT04787081 T AT 04787081T AT 04787081 T AT04787081 T AT 04787081T AT E532853 T1 ATE532853 T1 AT E532853T1
Authority
AT
Austria
Prior art keywords
plasmid dna
producing pharmaceutical
pharmaceutical quality
order
purification steps
Prior art date
Application number
AT04787081T
Other languages
English (en)
Inventor
Francis Blanche
Michel Couder
Nicolas Maestrali
David Gaillac
Thierry Guillemin
Original Assignee
Aventis Pharma Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Sa filed Critical Aventis Pharma Sa
Application granted granted Critical
Publication of ATE532853T1 publication Critical patent/ATE532853T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/06—Lysis of microorganisms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • A61K48/0091—Purification or manufacturing processes for gene therapy compositions
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
    • C12M47/00—Means for after-treatment of the produced biomass or of the fermentation or metabolic products, e.g. storage of biomass
    • C12M47/06—Hydrolysis; Cell lysis; Extraction of intracellular or cell wall material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/1003—Extracting or separating nucleic acids from biological samples, e.g. pure separation or isolation methods; Conditions, buffers or apparatuses therefor

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Mycology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Public Health (AREA)
  • Biophysics (AREA)
  • Analytical Chemistry (AREA)
  • Plant Pathology (AREA)
  • Manufacturing & Machinery (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Physics & Mathematics (AREA)
  • Veterinary Medicine (AREA)
  • Cell Biology (AREA)
  • Sustainable Development (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • Medicinal Preparation (AREA)
AT04787081T 2003-09-17 2004-09-17 Verfahren zur herstellung einer plasmid-dna in pharmazeutischer qualität ATE532853T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US50346403P 2003-09-17 2003-09-17
US56300804P 2004-04-19 2004-04-19
PCT/EP2004/011437 WO2005026331A2 (en) 2003-09-17 2004-09-17 Method of preparation of pharmaceutically grade plasmid dna

Publications (1)

Publication Number Publication Date
ATE532853T1 true ATE532853T1 (de) 2011-11-15

Family

ID=42827706

Family Applications (1)

Application Number Title Priority Date Filing Date
AT04787081T ATE532853T1 (de) 2003-09-17 2004-09-17 Verfahren zur herstellung einer plasmid-dna in pharmazeutischer qualität

Country Status (18)

Country Link
US (1) US20070111221A1 (de)
EP (1) EP1664277B1 (de)
JP (1) JP2007505613A (de)
KR (1) KR101094032B1 (de)
CN (1) CN1882682B (de)
AT (1) ATE532853T1 (de)
AU (2) AU2004272748C1 (de)
BR (1) BRPI0413907A (de)
CA (1) CA2536931A1 (de)
EA (1) EA009447B1 (de)
ES (1) ES2376173T3 (de)
HK (1) HK1096994A1 (de)
IL (1) IL174147A0 (de)
MX (1) MXPA06003004A (de)
NO (1) NO20061659L (de)
NZ (1) NZ545449A (de)
PT (1) PT1664277E (de)
WO (1) WO2005026331A2 (de)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2559368A1 (en) * 2004-04-19 2005-10-27 Centelion Method for purifying plasmid dna
EP1817423B1 (de) * 2004-11-30 2015-01-07 Merial Ltd. Mischvorrichtungen zur chemischen lysis von zellen
JP2010500042A (ja) * 2006-08-15 2010-01-07 ビーエーエスエフ ソシエタス・ヨーロピア 産生細胞からのタンパク質単離方法
WO2008045505A2 (en) 2006-10-10 2008-04-17 Xenomics, Inc. Compositions, methods and kits for isolating nucleic acids from body fluids using anion exchange media
PT2115010E (pt) * 2007-02-28 2012-03-09 Lipoxen Technologies Ltd Redução de endotoxinas em ácidos polisiálicos
EP2153260B1 (de) * 2007-05-23 2017-01-25 VGXI, Inc. Zusammensetzung mit einer hohen konzentration an biologisch aktiven molekülen und verfahren zu ihrer herstellung
EP2160459A2 (de) 2007-05-23 2010-03-10 Nature Technology Corp. Verbesserte e. coli-plasmid-dna-herstellung
US20080299621A1 (en) * 2007-05-31 2008-12-04 Ge Healthcare Uk Limited Miniprep system for simple and rapid plasmid dna extraction
US20090258932A1 (en) * 2008-04-09 2009-10-15 Viromed Co., Ltd. Lyophilized DNA Formulations for Enhanced Expression of Plasmid DNA
WO2011057199A1 (en) * 2009-11-06 2011-05-12 Adenios, Inc. Compositions for treating cns disorders
RU2488406C1 (ru) * 2012-02-16 2013-07-27 Общество с ограниченной ответственностью "НТфарма" Фармацевтическая композиция для терапии острых токсических состояний
RU2489168C1 (ru) * 2012-02-28 2013-08-10 Общество с ограниченной ответственностью "НТфарма" Фармацевтическая композиция, продуцирующая антиоксидантный, антимикробный, антитоксический белок - лактоферрин человека, способ ее получения и способ терапии
EP2682168A1 (de) 2012-07-02 2014-01-08 Millipore Corporation Reinigung biologischer Moleküle
CN104099321A (zh) * 2014-07-10 2014-10-15 广州市军科泰特医药科技有限公司 抗肺癌T-VISA-BikDD质粒的制备方法
CA2971830A1 (en) * 2014-12-29 2016-07-07 Bonac Corporation Composition containing nucleic acid molecule stably
CN106884011B (zh) * 2015-12-16 2020-11-17 固安鼎泰海规生物科技有限公司 一种规模化质粒纯化的联合液相层析分离方法
JP2019514394A (ja) 2016-05-06 2019-06-06 マックス−プランク−ゲゼルシャフト・ツア・フェルデルング・デア・ヴィッセンシャフテン・エー・ファオ プラグフローチューブ型バイオリアクター、それを含むシステム、およびウイルスの調製のための方法
JP7457660B2 (ja) * 2018-05-31 2024-03-28 ブイジーエックスアイ，インコーポレイティド ポリヌクレオチドを単離及び精製するための溶解コイル装置及びその使用
IL296722A (en) 2020-03-31 2022-11-01 Richter Helm Biologics Gmbh & Co Kg Methods for the production of plasmid DNA
CN111394427B (zh) * 2020-04-22 2023-04-11 宁波市博坤生物科技有限公司 一种含泥土检材中微量dna的提取方法
EP3906982B1 (de) 2020-05-08 2022-03-16 AXAGARIUS GmbH & Co. KG Verfahren zur plasmidreinigung unter gleichzeitiger abreicherung von endotoxinen
JP2021074018A (ja) * 2021-02-12 2021-05-20 マックス−プランク−ゲゼルシャフト・ツア・フェルデルング・デア・ヴィッセンシャフテン・エー・ファオ プラグフローチューブ型バイオリアクター、それを含むシステム、およびウイルスの調製のための方法
CN115404232A (zh) * 2021-05-10 2022-11-29 艾棣维欣(苏州)生物制品有限公司 用于提取细菌中质粒dna的方法
CN113332869B (zh) * 2021-06-23 2022-12-23 苏州沃美生物有限公司 混合装置和方法以及重组大肠杆菌质粒提取方法
WO2024086213A2 (en) * 2022-10-19 2024-04-25 Abec, Inc. Cell lysis and plasmid isolation system
CN117187069B (zh) * 2023-09-18 2024-04-05 苏州依科赛生物科技股份有限公司 一种碱裂解工艺的大肠杆菌hcp检测方法

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2692764A (en) * 1951-01-19 1954-10-26 Howe Baker Corp Mixing apparatus
JPS5321458A (en) * 1976-08-11 1978-02-27 Hitachi Ltd Device for mixing fluids
US4737349A (en) * 1985-11-01 1988-04-12 Ciba-Geigy Corporation Tubular reactor for heterogeneous reactions
US5096818A (en) * 1990-06-04 1992-03-17 Autogen Instruments, Inc. Nucleic acid separation method
US5561064A (en) * 1994-02-01 1996-10-01 Vical Incorporated Production of pharmaceutical-grade plasmid DNA
US6197553B1 (en) * 1994-07-15 2001-03-06 Merck & Co., Inc. Method for large scale plasmid purification
US5837529A (en) * 1994-10-17 1998-11-17 Genzyme Corporation Method for lysing cells
FR2728264B1 (fr) * 1994-12-16 1997-01-31 Rhone Poulenc Rorer Sa Purification d'adn par formation de triple helice avec un oligonucleotide immobilise
US5840254A (en) * 1995-06-02 1998-11-24 Cdc Technologies, Inc. Apparatus for mixing fluids for analysis
EP0811055B1 (de) * 1995-12-21 2004-06-09 Genzyme Corporation Methode zur zellyse
FR2746412B1 (fr) * 1996-03-21 1998-06-12 Rhone Poulenc Rorer Sa Purification d'adn plasmidique de qualite pharmaceutique
US7026468B2 (en) * 1996-07-19 2006-04-11 Valentis, Inc. Process and equipment for plasmid purification
US7807822B2 (en) * 1996-08-01 2010-10-05 Robert Bridenbaugh Methods for purifying nucleic acids
US5721120A (en) * 1996-10-02 1998-02-24 Merck & Co., Inc. Method of disrupting cultured cells using an impinging jet device
FR2773818B1 (fr) * 1998-01-21 2000-02-18 Pasteur Merieux Serums Vacc Procede et dispositif de lyse de bacteries
GB2338236B (en) * 1998-06-13 2003-04-09 Aea Technology Plc Microbiological cell processing
US6664049B1 (en) * 1999-01-20 2003-12-16 Aventis Pasteur S.A. Method and device for cell lysis
WO2000073318A1 (en) * 1999-05-28 2000-12-07 Bio Science Contract Production Corporation Methods of dna purification and purified dna
EP1224326A1 (de) * 1999-10-02 2002-07-24 Bioneer Corporation; Gerät zur automatischen reinigung von dna
WO2002023161A1 (en) * 2000-09-18 2002-03-21 University Of Washington Microfluidic devices for rotational manipulation of the fluidic interface between multiple flow streams
EP1554398A4 (de) * 2002-09-13 2005-12-14 Valentis Inc VORRICHTUNG UND VERFAHREN ZUR REINIGUNG VON NUKLEINSûUREN IM PRûPARATIVEN MASSSTAB
US20040157244A1 (en) * 2002-12-23 2004-08-12 Vical Incorporated Process for purification of plasmid DNA

Also Published As

Publication number Publication date
CN1882682B (zh) 2010-06-16
PT1664277E (pt) 2012-01-17
EP1664277B1 (de) 2011-11-09
IL174147A0 (en) 2006-08-01
AU2004272748A1 (en) 2005-03-24
EA200600579A1 (ru) 2006-10-27
AU2010200801A1 (en) 2010-03-25
WO2005026331A3 (en) 2005-11-17
JP2007505613A (ja) 2007-03-15
BRPI0413907A (pt) 2006-10-24
NZ545449A (en) 2009-07-31
KR20060086941A (ko) 2006-08-01
ES2376173T3 (es) 2012-03-09
AU2004272748C1 (en) 2010-07-08
CN1882682A (zh) 2006-12-20
CA2536931A1 (en) 2005-03-24
US20070111221A1 (en) 2007-05-17
KR101094032B1 (ko) 2011-12-19
HK1096994A1 (en) 2007-06-15
MXPA06003004A (es) 2006-06-23
EP1664277A2 (de) 2006-06-07
WO2005026331A2 (en) 2005-03-24
AU2004272748B2 (en) 2009-12-03
NO20061659L (no) 2006-06-13
EA009447B1 (ru) 2007-12-28

Similar Documents

Publication Publication Date Title
ATE532853T1 (de) Verfahren zur herstellung einer plasmid-dna in pharmazeutischer qualität
ATE496990T1 (de) Verfahren zur herstellung von plasmid dns in pharmazeutischer qualität
PT1232502E (pt) Particulas de vidro magneticas, metodo para a sua preparacao e suas utilizacoes
WO2007017229A3 (de) Verfahren für die kontinuierliche zielgerichtete evolution von proteinen in vitro
GB2575930A (en) Nucleobase editors comprising nucleic acid programmable DNA binding proteins
EP2615112A3 (de) Gereinigte Immunoglobulinfusionsproteine und Verfahren zu deren Reinigung
WO2005010150A3 (en) Method for in vitro selection of 2’-substituted nucleic acids
MX2021000211A (es) Metodos y productos para transfeccion de celulas.
WO2003040687A3 (en) Isolation and purification of nucleic acids
DE60227653D1 (de) Verfahren zur herstellung von l-aminosäuren, unter verwendung von stämmen aus der familie der enterohalten
ATE369430T1 (de) Methoden zur herstellung von nukleotidintegrasen
CY1111401T1 (el) Μεθοδος καθαρισμου πλασμιδιακου dna
ATE371731T1 (de) Verfahren zur skalierbaren reinigung von plasmid- dns
WO2004081166A3 (de) Nukleotidsequenzen coryneformer bakterien codierend für am l-serinstoffwechsel beteiligte proteine sowie verfahren zur mikrobiellen herstellung von l-serin
WO2006021453A3 (en) Optimized nucleotide sequences encoding sgp 130
CN1914319B (zh) 色谱分离核酸混合物的方法
ATE332971T1 (de) Typ ii dns polymerase aus pyrococcus abyssi
ATE321062T1 (de) Verfahren zur herstellung endotoxinfreier nukleinsäuren
WO2005072092A3 (en) Systems for tightly regulated gene expression
WO2006026125A3 (en) Improved strains of e. coli for plasmid dna production
WO2006081529A3 (en) Compositions and processes for improved plasmid dna production
WO2006055040A3 (en) Identification of proteins in a genome
WO2002024904A3 (de) Verfahren zur herstellung von ribonukleinsäure (rns)
EP0792933A3 (de) Enzym mit LeuDH-Aktivität, dafür codierende Nukleotid-Sequenz und Verfahren zur Herstellung des Enzyms
ATE352632T1 (de) Dna-expressionskonstrukt zur multiplen genexpression